These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25442272)

  • 1. In vitro effect of important herbal active constituents on human cytochrome P450 1A2 (CYP1A2) activity.
    Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
    Phytomedicine; 2014 Oct; 21(12):1645-50. PubMed ID: 25442272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibitory effect of piperlonguminine isolated from Piper longum on human cytochrome P450 1A2.
    Song M; Hwang JY; Lee MY; Jee JG; Lee YM; Bae JS; Kim JA; Lee SH; Lee S
    Arch Pharm Res; 2014 Aug; 37(8):1063-8. PubMed ID: 24194261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of CYP1A2 and 2C9 inhibition potential of Withania somnifera and Centella asiatica in human liver microsomes.
    Savai J; Varghese A; Pandita N; Chintamaneni M
    Drug Metab Pers Ther; 2015 Jun; 30(2):137-41. PubMed ID: 25938222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.
    Peterson S; Lampe JW; Bammler TK; Gross-Steinmeyer K; Eaton DL
    Food Chem Toxicol; 2006 Sep; 44(9):1474-84. PubMed ID: 16762476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of active constituents and extracts of Orthosiphon stamineus on the activities of three major human cDNA-expressed cytochrome P450 enzymes.
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    Chem Biol Interact; 2011 Mar; 190(1):1-8. PubMed ID: 21276781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational and in vitro studies on the inhibitory effects of herbal compounds on human cytochrome P450 1A2.
    Yang LP; Zhou ZW; Chen XW; Li CG; Sneed KB; Liang J; Zhou SF
    Xenobiotica; 2012 Mar; 42(3):238-55. PubMed ID: 21970686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.
    Manda VK; Avula B; Chittiboyina AG; Khan IA; Walker LA; Khan SI
    Xenobiotica; 2016; 46(2):117-25. PubMed ID: 26247834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoids eupatorin and sinensetin present in Orthosiphon stamineus leaves inhibit inflammatory gene expression and STAT1 activation.
    Laavola M; Nieminen R; Yam MF; Sadikun A; Asmawi MZ; Basir R; Welling J; Vapaatalo H; Korhonen R; Moilanen E
    Planta Med; 2012 May; 78(8):779-86. PubMed ID: 22516932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine.
    Zhao Y; Hellum BH; Liang A; Nilsen OG
    Phytother Res; 2012 Feb; 26(2):277-83. PubMed ID: 21678521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids.
    Zhai S; Dai R; Friedman FK; Vestal RE
    Drug Metab Dispos; 1998 Oct; 26(10):989-92. PubMed ID: 9763404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ortho-Methylarylamines as Time-Dependent Inhibitors of Cytochrome P450 1A1 Enzyme.
    Sridhar J; Liu J; Komati R; Schroeder R; Jiang Q; Tram P; Riley K; Foroozesh M
    Drug Metab Lett; 2017; 10(4):270-277. PubMed ID: 28000546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibitory effects of mollugin on CYP1A2 in human liver microsomes.
    Kim H; Choi HK; Jeong TC; Jahng Y; Kim DH; Lee SH; Lee S
    Food Chem Toxicol; 2013 Jan; 51():33-7. PubMed ID: 23000442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Procarcinogen Activating Enzyme CYP1A2 Activity and Free Radical Formation by Caffeic Acid and its Amide Analogues.
    Narongchai P; Niwatananun K; Narongchai S; Kusirisin W; Jaikang C
    Drug Metab Lett; 2016; 10(3):187-194. PubMed ID: 27292117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2.
    Yang AH; He X; Chen JX; He LN; Jin CH; Wang LL; Zhang FL; An LJ
    Chem Biol Interact; 2015 Jul; 237():133-40. PubMed ID: 26091900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro.
    Yim SK; Kim K; Chun S; Oh T; Jung W; Jung K; Yun CH
    Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2.
    Guo J; Zhu X; Badawy S; Ihsan A; Liu Z; Xie C; Wang X
    Curr Drug Metab; 2021; 22(1):40-49. PubMed ID: 33397254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy.
    Langhammer AJ; Nilsen OG
    Phytother Res; 2014 Apr; 28(4):603-10. PubMed ID: 23843424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes.
    Zhang L; Wei MJ; Zhao CY; Qi HM
    Acta Pharmacol Sin; 2008 Dec; 29(12):1507-14. PubMed ID: 19026171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibitory effects of asiaticoside and madecassoside on human cytochrome P450.
    Winitthana T; Niwattisaiwong N; Patarapanich C; Tantisira MH; Lawanprasert S
    Toxicol In Vitro; 2011 Jun; 25(4):890-6. PubMed ID: 21349323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
    Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
    Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.